Summit Therapeutics Inc. · NASDAQ:SMMT
Summit Therapeutics Inc. shareholders
As of Jun 30, 2026, 238 institutions reported holding Summit Therapeutics Inc., 17.0% of its shares. Largest: Baker Bros. Advisors LP, Vanguard and Fidelity. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Summit Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 32.8M | 4.1% | −3.6M | Aug 14, 2026 |
| Vanguard | 11.8M | 1.5% | −138K | Aug 13, 2026 |
| Fidelity | 10M | 1.3% | −809K | Aug 13, 2026 |
| State Street | 9.54M | 1.2% | +2.51M | Aug 7, 2026 |
| BlackRock | 9.53M | 1.2% | −125K | Aug 7, 2026 |
| UBS | 5.32M | 0.67% | +1.56M | Aug 13, 2026 |
| Goldman Sachs | 4.51M | 0.57% | +4.2M | Aug 14, 2026 |
| T. Rowe Price | 3.89M | 0.49% | −4.38M | Aug 14, 2026 |
| Point72 Asset Management, L.P. | 3.7M | 0.46% | +2.91M | Aug 14, 2026 |
| Geode Capital | 3.43M | 0.43% | +111K | Aug 12, 2026 |